XLA patient with 7-month course of COVID-19 with persistent plasma SARS-CoV-2 load revealed a sustained non-inflammatory profile of myeloid cells in association with contained severity of disease, arguing in favor of the use of BTK inhibitors in SARS-COV-2 infection.
Keywords: BTK; COVID-19; SARS-CoV-2; X-linked agammaglobulinemia; innate immunity; monocytes.
© 2022 The Authors. European Journal of Haematology published by John Wiley & Sons Ltd.